A 37-year-old woman with a history of anorectal abscesses complains of pain in the perianal region. Physical examination reveals mild swelling, tenderness, and erythema of the perianal skin. She is prescribed oral ampicillin and asked to return for follow-up. Two days later, the patient presents with a high-grade fever, syncope, and increased swelling. Which of the following would be the most common mechanism of resistance leading to the failure of antibiotic therapy in this patient?

Production of beta-lactamase enzyme

Intrinsic absence of a target site for the drug

Use of an altered metabolic pathway

Altered structural target for the drug

An 18-year old college freshman presents to his university clinic because he has not been feeling well for the past two weeks. He has had a persistent headache, occasional cough, and chills without rigors. The patient’s vital signs are normal and physical exam is unremarkable. His radiograph shows patchy interstitial lung infiltrates and he is diagnosed with atypical pneumonia. The patient is prescribed azithromycin and takes his medication as instructed. Despite adherence to his drug regimen, he returns to the clinic one week later because his symptoms have not improved. The organism responsible for this infection is likely resistant to azithromycin through which mechanism?

Methylation of ribosomal binding site

Decreased binding to RNA polymerase

A 64-year-old female with type 2 diabetes mellitus comes to the physician because of a 1-week history of painful red swelling on her left thigh. Examination shows a 3- x 4-cm, tender, fluctuant mass. Incision and drainage of the abscess are performed. Culture of the abscess fluid grows gram-positive, coagulase-positive cocci that are resistant to oxacillin. Which of the following best describes the mechanism of resistance of the causal organism to oxacillin?

Altered target of the antibiotic

Decreased uptake of the antibiotic

Decreased activation of the antibiotic

A 61-year-old woman who recently emigrated from India comes to the physician because of a 2-month history of fever, fatigue, night sweats, and a productive cough. She has had a 5-kg (11-lb) weight loss during this period. She has a history of type 2 diabetes mellitus and poorly controlled asthma. She has had multiple asthma exacerbations in the past year that were treated with glucocorticoids. An x-ray of the chest shows a cavitary lesion of the posterior apical segment of the left upper lobe with consolidation of the surrounding parenchyma. The pathogen identified on sputum culture is found to be resistant to multiple drugs, including streptomycin. Which of the following mechanisms is most likely involved in bacterial resistance to this drug?

Alteration in 30S ribosomal subunit

Alteration in the sequence of gyrA genes

Upregulation of arabinosyl transferase production

Upregulation of mycolic acid synthesis

Inhibition of bacterial synthesis of RNA

A 29-year-old pregnant woman with no prior antibiotic exposure presents with gonorrhea. Culture of Neisseria gonorrhoeae shows resistance to penicillin, tetracycline, and fluoroquinolones. Genetic testing reveals she has a strain with chromosomal mutations in penA (mosaic allele), mtrR promoter, and gyrA. She reports her partner recently returned from Southeast Asia. Apply epidemiologic and resistance mechanism knowledge to determine the most appropriate management and public health action.

Treat with dual therapy (ceftriaxone plus azithromycin) and initiate partner notification with travel history documentation

Treat with ceftriaxone alone and report to local health department

Perform cephalosporin susceptibility testing before treatment initiation

Treat with azithromycin monotherapy due to pregnancy

Initiate spectinomycin therapy and routine partner notification only

A 67-year-old woman with persistent Enterococcus faecium bacteremia despite appropriate vancomycin therapy undergoes repeat culture. The isolate now shows vancomycin MIC of 128 μg/mL (previously 2 μg/mL). PCR testing reveals the presence of vanA gene cluster. Hospital epidemiology traces potential sources. What is the most likely mechanism by which this organism acquired high-level vancomycin resistance?

Transposon-mediated transfer from vancomycin-resistant enterococci

Spontaneous chromosomal mutation during therapy

Transformation with DNA from lysed resistant bacteria

Increased vancomycin efflux pump expression

Alteration in cell wall synthesis without genetic acquisition

A 31-year-old man with acute myeloid leukemia develops neutropenic fever during chemotherapy. Blood cultures grow Pseudomonas aeruginosa resistant to all tested antibiotics including polymyxins (colistin). Genetic analysis shows mutations in pmrA and pmrB genes, as well as arnB gene. What mechanism best explains this organism's resistance to polymyxins, and what therapeutic implication does this have?

Lipopolysaccharide modification reducing drug binding; limited treatment options remain

Efflux pump overexpression; combination therapy with efflux inhibitors

Porin loss preventing drug entry; carbapenem combination therapy indicated

Target site mutation; higher doses of polymyxins can overcome resistance

Enzymatic drug inactivation; polymyxin derivatives remain effective

Aminoglycoside resistance for USMLE Step 1: High-Yield Microbiology Lessons

Aminoglycoside MOA - Protein Factory Sabotage

Bactericidal inhibitors of protein synthesis that target the 30S ribosomal subunit.
Entry into Gram-negative bacteria is an oxygen-dependent process.

Mechanism of Disruption:
- Interferes with the initiation complex of peptide formation.
- Induces misreading of mRNA, leading to toxic, nonfunctional proteins.
- Causes breakdown of polysomes into nonfunctional monosomes.

⭐ Because aminoglycoside uptake requires oxygen, they are characteristically ineffective against anaerobic bacteria.

📌 Mnemonic: "Buy AT 30" (Aminoglycosides & Tetracyclines act on the 30S subunit).

Bacterial ribosome and antibiotic targets

Enzymatic Modification - The Main Defense

Most common mechanism of aminoglycoside resistance, mediated by Aminoglycoside-Modifying Enzymes (AMEs).
These enzymes, encoded by bacterial genes, transfer chemical groups to the drug, inactivating it.
- Acetylation via Aminoglycoside Acetyltransferases (AAC)
- Phosphorylation via Aminoglycoside Phosphotransferases (APH)
- Adenylation via Aminoglycoside Nucleotidyltransferases (ANT)
This structural change prevents the aminoglycoside from binding effectively to its target on the 30S ribosomal subunit.
As a result, protein synthesis is no longer inhibited, and the bacterium survives.
📌 Mnemonic for enzymes: Always Add Phosphate or Nucleotides (Acetyl, Phospho, Nucleotidyl).

Aminoglycoside action, resistance, and inhibition

⭐ The genes encoding AMEs are often carried on plasmids and transposons, allowing for rapid dissemination of resistance through horizontal gene transfer between bacteria.

Altered Target & Transport - Keeping the Drug Out

Altered Ribosomal Target:
- Mechanism: Methylation of 16S rRNA on the 30S ribosomal subunit.
- Enzyme: Plasmid-encoded rRNA methyltransferases.
- Result: Steric hindrance ↓ prevents aminoglycoside binding at the A-site. This confers broad, high-level resistance to most aminoglycosides.
Impaired Drug Transport:
- Uptake: Requires an oxygen-dependent active transport system linked to the electron transport chain.
- Resistance Mechanisms:
  - Mutation or loss of porin channels (Gram-negatives) limits entry.
  - Disruption of the electron transport chain ↓ eliminates the electrical gradient needed for inner membrane transport.

⭐ Intrinsic Resistance: Anaerobes are intrinsically resistant to aminoglycosides because they lack the necessary oxygen-dependent transport system to move the drug across the cell membrane.

Antibiotic action vs. bacterial resistance

High‑Yield Points - ⚡ Biggest Takeaways

The primary mechanism of resistance is enzymatic modification (e.g., acetylation, phosphorylation) by plasmid-encoded transferase enzymes.

Resistance genes are readily transferred between bacteria on plasmids and transposons, facilitating rapid spread.

Another key mechanism is the alteration of the ribosomal target, specifically through mutations in the 16S rRNA of the 30S subunit.

Reduced uptake or active efflux of the drug out of the cell also confers resistance.

This is a major clinical problem for serious aerobic Gram-negative infections, particularly Pseudomonas aeruginosa.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play